Artikel ; Online: Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives.
Journal of hematology & oncology
2024 Band 17, Heft 1, Seite(n) 25
Abstract: Hepatocellular carcinoma (HCC) is a major health concern worldwide, with limited therapeutic options and poor prognosis. In recent years, immunotherapies such as immune checkpoint inhibitors (ICIs) have made great progress in the systemic treatment of ... ...
Abstract | Hepatocellular carcinoma (HCC) is a major health concern worldwide, with limited therapeutic options and poor prognosis. In recent years, immunotherapies such as immune checkpoint inhibitors (ICIs) have made great progress in the systemic treatment of HCC. The combination treatments based on ICIs have been the major trend in this area. Recently, dual immune checkpoint blockade with durvalumab plus tremelimumab has also emerged as an effective treatment for advanced HCC. However, the majority of HCC patients obtain limited benefits. Understanding the immunological rationale and exploring novel ways to improve the efficacy of immunotherapy has drawn much attention. In this review, we summarize the latest progress in this area, the ongoing clinical trials of immune-based combination therapies, as well as novel immunotherapy strategies such as chimeric antigen receptor T cells, personalized neoantigen vaccines, oncolytic viruses, and bispecific antibodies. |
---|---|
Mesh-Begriff(e) | Humans ; Carcinoma, Hepatocellular/therapy ; Carcinoma, Hepatocellular/immunology ; Liver Neoplasms/therapy ; Liver Neoplasms/immunology ; Tumor Microenvironment/immunology ; Immunotherapy/methods ; Immune Checkpoint Inhibitors/therapeutic use ; Cancer Vaccines/therapeutic use ; Animals |
Chemische Substanzen | Immune Checkpoint Inhibitors ; Cancer Vaccines |
Sprache | Englisch |
Erscheinungsdatum | 2024-04-29 |
Erscheinungsland | England |
Dokumenttyp | Review ; Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2429631-4 |
ISSN | 1756-8722 ; 1756-8722 |
ISSN (online) | 1756-8722 |
ISSN | 1756-8722 |
DOI | 10.1186/s13045-024-01549-2 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.